Evaluation of the diagnostic utility of individual parameters in the disseminated intravascular coagulation ( DIC ) panel for use in underresourced settings

References: 1. Toh C, Alhamdi Y. Current consideration and management of disseminated intravascular coagulation. Hematology. 2013;2013(1):286-291. 2. Levi M, Toh C, Thachil J, Watson H. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology. 2009;145(1):24-33. 3. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001; 86(5):1327-1330. 4. Wada H, Asakura H, Okamoto K, Iba T, Uchiyama T, Kawasugi K et al. Expert consensus for the treatment of disseminated intravascular coagulation in Japan. Thrombosis Research. 2010;125(1):6-11. 5. Kinasewitz G, Zein J, Lee G, Nazir S, Taylor F. Prognostic value of a simple evolving disseminated intravascular coagulation score in patients with severe sepsis*. Critical Care Medicine. 2005;33(10):2214-2221. 6. Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S et al. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. Journal of Thrombosis and Haemostasis. 2013;11(4):761-767. 7. Levi M, ten Cate H. Disseminated Intravascular Coagulation. New England Journal of Medicine. 1999;341(8):586-592. 8. Dhainaut J, Yan S, Joyce D, Pettila V, Basson B, Brandt J et al. Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation1. Journal of Thrombosis and Haemostasis. 2004;2(11):1924-1933. Society: ISTH JMHW JAAM